Apr 2, 2019 5:20 pm EDT NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference
Mar 11, 2019 7:00 am EDT NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)
Mar 7, 2019 4:50 pm EST NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
Feb 19, 2019 7:00 am EST NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
Jan 28, 2019 7:00 am EST NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
Dec 12, 2018 7:35 am EST NeoGenomics Announces Pricing on Secondary Offering of Common Stock by Selling Stockholder
Dec 11, 2018 4:10 pm EST NeoGenomics Announces Secondary Offering of Common Stock by Selling Stockholder
Nov 30, 2018 5:01 pm EST QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
